Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Cipher Pharmaceuticals Inc
T.CPH
Alternate Symbol(s):
CPHRF
Healthcare
Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology...
products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:CPH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
Rsoleblocka
X
View Profile
View Bullboard History
Post by
Rsoleblocka
on Nov 29, 2021 4:16pm
just a bit bitter
woulda coulda shoulda......i shall remain optomistic!
(3522)
•••
nozzpack
X
View Profile
View Bullboard History
Comment by
nozzpack
on Nov 29, 2021 4:09pm
RE:RE:Here we go
It's the sheeple getting spooked. Nice to see those shares being bought back..
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(126)
•••
Daudau11
X
View Profile
View Bullboard History
Comment by
Daudau11
on Nov 29, 2021 2:08pm
RE:Here we go
I hope so I have a bid near that price and I want to get filled!!
(0)
•••
Rsoleblocka
X
View Profile
View Bullboard History
Post by
Rsoleblocka
on Nov 29, 2021 12:37pm
Here we go
Will it hit 1.50 this week?
(0)
•••
Rsoleblocka
X
View Profile
View Bullboard History
Post by
Rsoleblocka
on Nov 29, 2021 12:15pm
I blew it
If this ever hits 2 I am out.
(3522)
•••
nozzpack
X
View Profile
View Bullboard History
Post by
nozzpack
on Nov 25, 2021 8:26am
Sun Pharma Q2 CC Transcript Nov 2012
Sun Q2 would be the same as just reported CPH Q3. Getting a handle on Absorica sales in the US is now complicated by having three Absorica products, Absorica, Absorica LD and the very recently
...more
(3522)
•••
nozzpack
X
View Profile
View Bullboard History
Comment by
nozzpack
on Nov 23, 2021 7:07pm
RE:RE:Epuris Sales in Mexico
Brazil is the second largest isotrention in market in the world. Brazil dominated the Latin America acne medication market and was valued at over USD 110.9 million in the year 2017. I don't know
...more
(3522)
•••
nozzpack
X
View Profile
View Bullboard History
Comment by
nozzpack
on Nov 23, 2021 6:56pm
RE:Epuris Sales in Mexico
Thank you. Cph received a royalty on Mexican sales. Italmax had revenues of $142 m US in 2920, so it has some heft. Why Epuris continues to gain market share in Canada but not in the US is the
...more
(164)
•••
Northforce13
X
View Profile
View Bullboard History
Comment by
Northforce13
on Nov 23, 2021 6:19pm
RE:Epuris Sales in Mexico
I expect (pure guess) their Mexico epuris sales will be quite small, a fraction of Canada's What is a bit intriguing is how CPH continues to grow market share in Canada, at 43%, without any
...more
(3522)
•••
nozzpack
X
View Profile
View Bullboard History
Post by
nozzpack
on Nov 23, 2021 11:28am
Epuris Sales in Mexico
The isotretinion markets in Canada and Mexico are broadly similar. It seems to me that Ciphers Epuris sales in Mexico will be about the same as that in Canada. In Canada, CPH receives just
...more
(42)
•••
flashcash
X
View Profile
View Bullboard History
Comment by
flashcash
on Nov 19, 2021 1:39pm
RE:Bought and Cancelled 132,800 shares in October
Perhaps the share buy back will eventually put us under the fund managers eyes.
(3522)
•••
nozzpack
X
View Profile
View Bullboard History
Post by
nozzpack
on Nov 18, 2021 1:06pm
Bought and Cancelled 132,800 shares in October
Eom
(3522)
•••
nozzpack
X
View Profile
View Bullboard History
Comment by
nozzpack
on Nov 15, 2021 2:37pm
RE:Also overlooked and Positive was this
The Mexican isotretinoin market is a steadily growing market and is expected to show continued growth in the coming years. The value of the Mexican isotretinoin market was approximately US$20
...more
(1)
•••
maxxie3
X
View Profile
View Bullboard History
Post by
maxxie3
on Nov 14, 2021 4:17pm
Also overlooked and Positive was this
Subsequent to quarter end, Italmex, our distribution partner for isotretinoin products in Mexico, received approval of Epuris 10mg, and 20mg in Mexico by COFEPRIS. Under the terms
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >